Our findings corroborate the causal relationship between elevated IL-17A, LIF-R expression, and CKD, enriching the understanding of CKD's inflammatory underpinnings and offering novel avenues for targeted therapy. The gene discussed is LIFR; the disease is chronic kidney disease.